Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The BALANCE trial program did launch in Medicaid in May 2026 and is scheduled to conclude there at the end of 2031
PLoS One 8 (4), e61965
Retatrutide decreased HbA1c by 2.02% in a phase II clinical trial, while dulaglutide 1.5 mg decreased HbA1c by 1.14% and a placebo decreased it by 0.01% [109]
Paired with our targeted 10 pack Peel Pads to gently exfoliate, this combination creates the perfect canvas for smoother, plumper lips with enhanced color and protection.A Peel to Reveal Your Most Beautiful Skin: The Universal Daily Peel is our one step, triple action peel that will help "shed" some light on younger-looking, more radiant skin in less time, less steps, and less cost
10.1161/01.HYP.0000130484.20501.df Hypertension
Pancreatitis awareness GLP-1 receptor agonists carry a theoretical risk of pancreatitis, though this has been rare in retatrutide trials specifically
US$ 26.65
US$ 21.93
US$ 29.13
US$ 25.86
US$ 25.40
US$ 28.87
